Arbutus Biopharma Corporation - Common Stock (NQ:ABUS)
4.335
+0.185
(+4.46%)
Streaming Delayed Price
Updated: 12:28 PM EDT, Apr 13, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 541,912 |
| Open | 4.140 |
| Bid (Size) | 4.330 (2,600) |
| Ask (Size) | 4.340 (400) |
| Prev. Close | 4.150 |
| Today's Range | 4.130 - 4.340 |
| 52wk Range | 2.940 - 5.100 |
| Shares Outstanding | 99,161,234 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Arbutus (ABUS) Q2 Revenue Surges 529% ↗
August 06, 2025
Arbutus Provides 2025 Corporate and Financial Update
January 13, 2025
Frequently Asked Questions
Is Arbutus Biopharma Corporation - Common Stock publicly traded?
Yes, Arbutus Biopharma Corporation - Common Stock is publicly traded.
What exchange does Arbutus Biopharma Corporation - Common Stock trade on?
Arbutus Biopharma Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Arbutus Biopharma Corporation - Common Stock?
The ticker symbol for Arbutus Biopharma Corporation - Common Stock is ABUS on the Nasdaq Stock Market
What is the current price of Arbutus Biopharma Corporation - Common Stock?
The current price of Arbutus Biopharma Corporation - Common Stock is 4.335
When was Arbutus Biopharma Corporation - Common Stock last traded?
The last trade of Arbutus Biopharma Corporation - Common Stock was at 04/13/26 12:28 PM ET
What is the market capitalization of Arbutus Biopharma Corporation - Common Stock?
The market capitalization of Arbutus Biopharma Corporation - Common Stock is 429.86M
How many shares of Arbutus Biopharma Corporation - Common Stock are outstanding?
Arbutus Biopharma Corporation - Common Stock has 430M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.